Skip to main content
. 2013 Dec 19;11(3):572–582. doi: 10.1007/s13311-013-0245-y

Table 1.

Design and parameters of clinical studies of invasive cortical stimulation in stroke

Study [ref.] Design Lesion Baseline function Localization Intra-cortical mapping Parameters Duration of rehabilitation Endpoint Efficacy results
Brown et al. [19] Case study Subcortical Fugl–Meyer = 36 fMRI activation in peri-rolandic M1 Intraoperative confirmation of functioning pathways from fMRI target 3 × 3 array, 50 Hz, 100-ms pulses current ~4.5 mA 3 wks Case report ∆ Fugl–Meyer = 10
Brown et al. [20] Unblinded, phase I, multicenter clinical trial.
Investigational and control groups
Cortical or subcortical Fugl–Meyer: investigational = 36 ± 9
Fugl–Meyer: control = 41 ± 5
fMRI activation in peri-rolandic M1 Intraoperative confirmation of functioning pathways from fMRI target in 83 % of patients in investigational group 3 × 3 array, 50 Hz, 50 % movement threshold.
Biphasic pulses.
Outer rows anode and cathode
2 × 1.5-h sessions, daily × 3 wks Safety ∆ Fugl–Meyer = 10 in investigational vs 1.9 in control group
Levy et al. [18] Huang et al. [17] Unblinded, phase II, randomized 7-center trial.
Investigational and control groups
Cortical, capsular, or pontine Fugl–Meyer: investigational = 34.4 ± 8.9
Fugl–Meyer: control 30.5 ± 7.3
fMRI activation in peri-rolandic M1 Intraoperative confirmation not discussed, but during thresholding in rehabilitation, stimulation elicited contralateral response in 42 % of patients in investigational group 2 × 3 array, 50 or 101 Hz, 50 % movement threshold. Outer rows anode and cathode. 2.7 × 2.6 cm2 area 2.5 h daily for 6 wks Efficacy = ∆ Fugl–Meyer = 3.5 ∆ Fugl– Meyer = 5.5 in investigational vs 1.9 in control.
67 % had clinically meaningful ∆ in investigational group
Harvey et al. (2009) [21] (results in press release Northstar Neuroscience Inc.) Single-blinded, randomized multicenter phase III trial.
Investigational and control groups
Cortical or subcortical above midbrain Fugl–Meyer: investigational = 37.6
Fugl–Meyer: control 37.6
fMRI activation in peri-rolandic M1 Intraoperative confirmation not discussed, but during thresholding in rehabilitation, stimulation elicited contralateral response in 15.3 % of patients in investigational group 2 × 3 array, 50 Hz, 50 % movement threshold. Outer rows anode and cathode 2.5 h daily for 6 wks Efficacy = ∆ Fugl–Meyer = 4.5 points + ∆ Arm Motor Ability Test of 0.21 ∆ Fugl–Meyer + Arm Motor Ability = 4.3 and 0.37 in investigational group vs = 4. 0 and 0.26 in control group.
30.8 % had clinically meaningful ∆ in investigational group

fMRI functional magnetic resonance